← back to search

Camilla Fowst

Pfizer (Italy) · IT
Area of research
Pulmonary and Respiratory Medicine · Genetics
Research interest
Research interests include Estrogen and related hormone effects, Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies, and Breast Cancer Treatment Studies.
h-index
21
citations
9,798
works
36
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
New England Journal of Medicine 2020cited by 1,463position: middledoi
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
New England Journal of Medicine 2019cited by 2,524position: middledoi
Overall survival results from the randomized phase II study of palbociclib (P) in combination with letrozole (L) vs letrozole alone for frontline treatment of ER+/HER2– advanced breast cancer (PALOMA-1; TRIO-18).
Journal of Clinical Oncology 2017cited by 67position: middledoi
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
The Lancet Oncology 2014cited by 1,906position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Katalin Boér · Stanford University2 papers (2014–2017)Richard S. Finn · United States Olympic & Paralympic Committee2 papers (2014–2017)Tamás Pintér · Petz Aladár Megyei Oktató Kórház2 papers (2014–2017)Xin Huang · Lineage Cell Therapeutics (United States)2 papers (2014–2017)— · 2 papers (2014–2017)— · 2 papers (2014–2017)— · 2 papers (2014–2017)Dennis J. Slamon · APLA Health2 papers (2014–2017)— · 2 papers (2014–2017)John Crown · Lublin Oncology Center2 papers (2014–2017)Johannes Ettl · Kempten University of Applied Sciences2 papers (2014–2017)Marcus Schmidt · Universitäts Frauenklinik2 papers (2014–2017)Yaroslav Shparyk · Danylo Halytsky Lviv National Medical University2 papers (2014–2017)Sophia Randolph · Johannes Gutenberg University Mainz1 papers (2014–2014)István Láng · National Institute of Oncology1 papers (2017–2017)István Láng · National Healthcare Service Center1 papers (2014–2014)Sindy Kim · Pfizer (United States)1 papers (2017–2017)Sindy T. Kim · Texas Oncology1 papers (2014–2014)Igor Bondarenko · Dnipro State Medical University1 papers (2017–2017)